Results 21 to 30 of about 12,979 (220)

The Implementation of Persistent Spinal Pain Syndrome (PSPS): Mechanism‐Based Recommendations

Pain Practice, Volume 26, Issue 1, January 2026.
ABSTRACT Background In 2021, the term persistent spinal pain syndrome (PSPS) was introduced. PSPS type 2 (PSPS‐T2) replaced the unsatisfactory term failed back surgery syndrome (FBSS). PSPS type 1 (PSPS‐T1) is a clinical picture of signs and symptoms of FBSS but without prior surgery. PSPS applies to any spinal level.
Simon Thomson, Brian Simpson, Frank J. Huygen, Michael Stanton‐Hicks, Richard B. North, Giancarlo Barolat, Harriet Scott, Rui V. Duarte   +7 more
wiley   +1 more source

Diagnostic imaging of sacroiliac joints and the spine in the course of spondyloarthropathies

Polish Journal of Radiology, 2013
Summary Spondyloarthropathies belong to a group of rheumatic diseases, in which inflammatory changes affect mainly the sacroiliac joints, spine, peripheral joints, tendon, ligaments and capsule attachments (entheses).
I. Sudoł-Szopińska, A. Urbanik
semanticscholar   +1 more source

Risk of Dementia in The Patients with Inflammatory Arthritis

Alzheimer's &Dementia, Volume 21, Issue S6, December 2025.
Abstract Background Inflammation is an important mechanism of dementia. Inflammatory cells and cytokines largely contribute the pathophysiology of inflammatory arthritis. We evaluated the risk of dementia between the patients of inflammatory arthritis and matched population, using data from National Health Insurance Service.
Jun Hong Lee
wiley   +1 more source

Pyoderma Gangrenosum in Spain: Clinical Features, Therapeutic Management, and Outcomes in a 32‐Patient Case Series

Health Science Reports, Volume 8, Issue 12, December 2025.
ABSTRACT Background and Aims Pyoderma gangrenosum (PG) is a rare and challenging neutrophilic dermatosis characterized by painful, rapidly progressing necrotic ulcers. This study aimed to describe the demographic features, clinical presentations, associated systemic conditions, therapeutic approaches, and mortality risk factors in patients with PG.
José‐Manuel Ramos‐Rincón, Jorge Esteban‐Jarabo, Marina Senent, Isabel Belinchón‐Romero   +3 more
wiley   +1 more source

Economic Burden of Rheumatoid Arthritis in Iran: A Societal Perspective

Public Health Challenges, Volume 4, Issue 4, December 2025.
GRAPHICAL ABSTRACT This 2022 cross‐sectional study of 765 RA patients in Southern Iran revealed an annual economic burden of $6388 per patient, with biologic drugs dominating costs (84%). Moderate‐to‐severe cases cost 8% more than remission ($6729 vs. $6248).
Mehdi Rezaee, Farhad Lotfi, Ahmad Gholami, Jassem Azizpoor, Elham Aflaki, Afsaneh Vazin, Khosro Keshavarz   +6 more
wiley   +1 more source

The new proposal classification criteria for juvenile spondyloarthropathies

Pediatric Rheumatology Online Journal, 2014
Juvenile spondyloarthropathies (JSpA) are a group of rheumatologic diseases with a disease onset before 16 years of age and are characterized with enthesitis, lower extremity oligoarthritis, involvement of the axial skeleton and HLA B27 positivity.
M. Sezen, K. Barut, C. Açikel, O. Kasapcopur   +3 more
semanticscholar   +1 more source

Prevalence of vasculitis, systemic lupus erythematosus, rheumatoid arthritis, systemic sclerosis, idiopathic inflammatory myopathies and spondyloarthritis in Australia: a systematic review and meta‐analysis

Internal Medicine Journal, Volume 55, Issue 12, Page 1985-1996, December 2025.
ABSTRACT Background Systemic autoimmune rheumatic diseases (SARDs), including vasculitis, systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), systemic sclerosis (SSc), idiopathic inflammatory myopathies (IIM), spondyloarthritis (SpA), Sjogrens disease (SjD) and mixed connective tissue disease (MCTD), are rare but associated with substantial ...
L. Roper, E. Cameron, T. Yu, N. Li, M. Parker, N. Nassar, M. Nikpour   +6 more
wiley   +1 more source

Successful Treatment of Post‐SARS‐CoV‐2 Infection Reactive Arthritis With Secukinumab: A Case Report and Literature Review

Clinical Case Reports, Volume 13, Issue 11, November 2025.
ABSTRACT This case describes a rare occurrence of post‐SARS‐CoV‐2 infection reactive arthritis with psoriasiform lesions. The patient failed to respond to conventional therapies but responded well to secukinumab, underscoring that it may be a valuable treatment for refractory post‐SARS‐CoV‐2 infection reactive arthritis when conventional therapies fail.
Qi Zhao, Tianyu Yao, Danyue He, Jie Hu, Yulin Wang, Ruyi Wang, Yiyang Hu, Chengyu Li, Jia Cai, Xiangning Li, Lili Tang, Xing Fan   +11 more
wiley   +1 more source

Community‐based Acceptance and Commitment Therapy Programmes for rheumatic conditions: An acceptability and qualitative process evaluation study

British Journal of Health Psychology, Volume 30, Issue 4, November 2025.
Abstract Purpose Dissemination and implementation of socially prescribed community‐based programmes for individuals with rheumatic conditions remain rare. However, such programmes can help overcome key barriers, including limited access to evidence‐based psychological interventions, individuals' preference for psychosocial care outside of rheumatology ...
Vasiliki Christodoulou, Katerina Artemiou, Vasilis S. Vasiliou   +2 more
wiley   +1 more source

Core Set of Responsive and Discriminatory Measures for Use in Pragmatic Trials of Youth With Axial Juvenile Spondyloarthritis

Arthritis Care &Research, Volume 77, Issue 10, Page 1229-1239, October 2025.
Objective The objective of this study was to determine a core set of measures for youth with juvenile spondyloarthritis and axial disease (axJSpA), using the juvenile arthritis working group Outcome Measures in Rheumatology framework. Methods This was a prospective multicenter study of youth with axJSpA.
Timothy G. Brandon, Rui Xiao, Daniel J. Lovell, Edward Oberle, Matthew L. Stoll, Nancy A. Chauvin, Michael L. Francavilla, Walter P. Maksymowych, Pamela F. Weiss   +8 more
wiley   +1 more source